TrialPanorama/TrialPanorama-database huggingface dataset:
Study 38587557 — Surrogate Endpoint (SUR): Blood pressure
Study 38587645 — Safety Biomarker (SAF): SLC6A3
Genes: DAT
Study 38587643 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 38587643 — Predictive Biomarker (PRD): Hormone receptor
Study 38587846 — Safety Biomarker (SAF): Hyaluronic acid
Study 38588408 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 38588450 — Surrogate Endpoint (SUR): Blood pressure
Study 38588682 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 38588682 — Surrogate Endpoint (SUR): Pathological complete response
Study 38588682 — Predictive Biomarker (PRD): Hormone receptor
Study 38588926 — Surrogate Endpoint (SUR): Blood pressure
Study 38589451 — Surrogate Endpoint (SUR): Bone mineral density
Study 38589574 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study 38589574 — Predictive Biomarker (PRD): HRAS mRNA
Genes: HRAS; HRAS1
Study 38589574 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 38589630 — Predictive Biomarker (PRD): TRPV1 mRNA
Genes: TRPV1; VR1
Study 38589856 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study 38589856 — Predictive Biomarker (PRD): BTC mRNA
Genes: BTC
Study 38589856 — Predictive Biomarker (PRD): NLRP1 mRNA
Genes: NLRP1; CARD7; DEFCAP; KIAA0926; NAC; NALP1
Study 38589875 — Pharmacodynamic Biomarker (PDY): Platelet-derived growth factor B
Genes: PDGFB; PDGF2; SIS
Study 38590831 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 38590831 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 38591260 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 38591997 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 38592002 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 38592721 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 38592721 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 38593212 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study 38593221 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 38593241 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 38593241 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study 38593241 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 38593249 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 38593249 — Predictive Biomarker (PRD): RUNX3 mRNA
Genes: RUNX3; AML2; CBFA3; PEBP2A3
Study 38593348 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 38593943 — Surrogate Endpoint (SUR): Blood pressure
Study 38593947 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 38594435 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study 38594558 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study 38594603 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study 38594603 — Predictive Biomarker (PRD): AZIN2 mRNA
Genes: AZIN2; ADC; KIAA1945; ODCP
Study 38594621 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Cholinesterase
Genes: BCHE; CHE1
Study 38594621 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study 38594685 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study 38594905 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 38595129 — Safety Biomarker (SAF): Hyaluronic acid
Study 38595232 — Monitoring Biomarker (MOI): Cell-free DNA
Study 38595232 — Surrogate Endpoint (SUR): Serum creatinine
Study 38597249 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 38597399 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 38597860 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 38597988 — Predictive Biomarker (PRD): CPM mRNA
Genes: CPM
Study 38599221 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 38599257 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 38599257 — Surrogate Endpoint (SUR): Blood pressure
Study 38599522 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 38599522 — Surrogate Endpoint (SUR): Blood pressure
Study 38599715 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 38599894 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study 38599907 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 38600099 — Predictive Biomarker (PRD): NOTCH3 mRNA
Genes: NOTCH3
Study 38600278 — Surrogate Endpoint (SUR): Blood pressure
Study 38600471 — Predictive Biomarker (PRD): MAP2K1 mRNA
Genes: MAP2K1; MEK1; PRKMK1
Study 38600471 — Predictive Biomarker (PRD): MAP2K2 mRNA
Genes: MAP2K2; MEK2; MKK2; PRKMK2
Study 38600471 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study 38600583 — Predictive Biomarker (PRD): HMMR mRNA
Genes: HMMR; IHABP; RHAMM
Study 38600583 — Safety Biomarker (SAF): Hyaluronic acid
Study 38600915 — Surrogate Endpoint (SUR): Blood pressure
Study 38601063 — Surrogate Endpoint (SUR): Blood pressure
Study 38601147 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-B
Genes: AS
Study 38601147 — Safety Biomarker (SAF): HLA-DRB1
Genes: HLA-DR1B
Study 38602105 — Predictive Biomarker (PRD): PGD mRNA
Genes: PGD; PGDH
Study 38602417 — Predictive Biomarker (PRD): FGFR2 mRNA
Genes: FGFR2; BEK; KGFR; KSAM
Study 38602417 — Predictive Biomarker (PRD): FGFR1 mRNA
Genes: FGFR1; BFGFR; CEK; FGFBR; FLG; FLT2; HBGFR
Study 38602417 — Predictive Biomarker (PRD): FGFR3 mRNA
Genes: FGFR3; JTK4
Study 38602417 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 38602417 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study 38603720 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 38603720 — Predictive Biomarker (PRD): Small-inducible cytokine A11
Genes: CCL11; SCYA11
Study 38603973 — Predictive Biomarker (PRD): C-C motif chemokine 7
Genes: CCL7; MCP3; SCYA6; SCYA7
Study 38604815 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 38605166 — Predictive Biomarker (PRD): DST mRNA
Genes: DST; BP230; BP240; BPAG1; DMH; DT; KIAA0728
Study 38605374 — Surrogate Endpoint (SUR): Bone mineral density
Study 38605470 — Predictive Biomarker (PRD): AIRE mRNA
Genes: AIRE; APECED
Study 38605470 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 38605470 — Predictive Biomarker (PRD): IL17F
Genes: IL-17F; ML-1; ML1
Study 38605958 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 38606105 — Predictive Biomarker (PRD): DNAJB1 mRNA
Genes: DNAJB1; DNAJ1; HDJ1; HSPF1
Study 38606105 — Predictive Biomarker (PRD): PRKACA mRNA
Genes: PRKACA; PKACA
Study 38606105 — Safety Biomarker (SAF): Human leucocyte antigen
Study 38606196 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study 38606384 — Surrogate Endpoint (SUR): Blood pressure
Study 38606524 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 38606524 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 38606776 — Surrogate Endpoint (SUR): Blood pressure
Study 38606777 — Pharmacodynamic Biomarker (PDY): Guanine nucleotide exchange factor C9orf72
Genes: C9orf72; DENND9; DENNL72
Study 38607410 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study 38607410 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study 38607410 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 38608871 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 38609316 — Predictive Biomarker (PRD): SLAMF7 mRNA
Genes: SLAMF7; CS1; UNQ576/PRO1138
Study 38609316 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 38609322 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 38609522 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 38609684 — Surrogate Endpoint (SUR): Blood pressure
Study 38610004 — Predictive Biomarker (PRD): IDS mRNA
Genes: IDS; SIDS
Study 38610005 — Predictive Biomarker (PRD): ASL mRNA
Genes: ASL
Study 38610031 — Predictive Biomarker (PRD): PARP1 mRNA
Genes: PARP1; ADPRT; PPOL
Study 38610950 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 38610966 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study 38610966 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study 38610966 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 38610966 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 38610966 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study 38610966 — Predictive Biomarker (PRD): TTLL5 mRNA
Genes: TTLL5; KIAA0998; STAMP
Study 38613092 — Predictive Biomarker (PRD): CSF1R mRNA
Genes: CSF1R; FMS
Study 38613329 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 38613329 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 38614365 — Surrogate Endpoint (SUR): Blood pressure
Study 38614372 — Predictive Biomarker (PRD): CA1 mRNA
Genes: CA1
Study 38615070 — Surrogate Endpoint (SUR): Hemagglutination inhibition antibody
Study 38615657 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 38615657 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 38617471 — Monitoring Biomarker (MOI): HBV DNA
Study 38617566 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 38617599 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 38618203 — Surrogate Endpoint (SUR): Pathological complete response
Study 38618203 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 38618204 — Surrogate Endpoint (SUR): Blood pressure
Study 38619715 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 38619783 — Surrogate Endpoint (SUR): Blood pressure
Study 38619824 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 38620072 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 38620072 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 38620072 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 38620092 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 38621793 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 38622330 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 38622445 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study 38622488 — Predictive Biomarker (PRD): FMN1 mRNA
Genes: FMN1; FMN; LD
Study 38622520 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 38622671 — Surrogate Endpoint (SUR): Forced vital capacity
Study 38625671 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 38625729 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 38626080 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 38626807 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 38626958 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 38626974 — Predictive Biomarker (PRD): PLXNA2 mRNA
Genes: PLXNA2; KIAA0463; OCT; PLXN2; UNQ209/PRO235
Study 38627035 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 38627238 — Predictive Biomarker (PRD): FGFR1 mRNA
Genes: FGFR1; BFGFR; CEK; FGFBR; FLG; FLT2; HBGFR
Study 38627266 — Predictive Biomarker (PRD): LTB4R mRNA
Genes: LTB4R; BLT; BLT1; BLTR; CMKRL1; GPR16; P2RY7
Study 38627366 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 38627686 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study 38627722 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 38627722 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 38628555 — Predictive Biomarker (PRD): CYP2B6 mRNA
Genes: CYP2B6
Study 38628555 — Predictive Biomarker (PRD): CHRNA4 mRNA
Genes: CHRNA4; NACRA4
Study 38629062 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 38629312 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 38629811 — Predictive Biomarker (PRD): SST mRNA
Genes: SST
Study 38629811 — Predictive Biomarker (PRD): PVALB mRNA
Genes: PVALB
Study 38630551 — Predictive Biomarker (PRD); Safety Biomarker (SAF): MHC class I polypeptide-related sequence A
Genes: MICA; PERB11.1
Study 38630551 — Predictive Biomarker (PRD): MICB mRNA
Genes: MICB; PERB11.2
Study 38630781 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study 38630781 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 38630781 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 38630908 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 38631712 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 38631833 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 38632457 — Surrogate Endpoint (SUR): Blood pressure
Study 38632501 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 38632501 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 38632501 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 38633575 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 38633771 — Surrogate Endpoint (SUR): Blood pressure
Study 38634282 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 38634292 — Surrogate Endpoint (SUR): Blood pressure
Study 38635558 — Predictive Biomarker (PRD): FHL5 mRNA
Genes: FHL5; ACT
Study 38635762 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 38635932 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study 38637464 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 38637495 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 38637829 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 38638324 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 38638399 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 38638399 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 38638399 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 38638400 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 38638400 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 38638854 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 38638867 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 38638867 — Predictive Biomarker (PRD): CYP3A5 mRNA
Genes: CYP3A5
Study 38638867 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 38639359 — Predictive Biomarker (PRD): ERAL1 mRNA
Genes: ERAL1; HERA
Study 38639359 — Predictive Biomarker (PRD): KLHL17 mRNA
Genes: KLHL17; AF
Study 38639697 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 38639888 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 38639888 — Predictive Biomarker (PRD): TF mRNA
Genes: TF; PRO1400
Study 38639888 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DAND5 mRNA
Genes: DAND5; CER2; CKTSF1B3; GREM3; SP1
Study 38639888 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 38640200 — Predictive Biomarker (PRD): EIF2AK2 mRNA
Genes: EIF2AK2; PKR; PRKR
Study 38640200 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 38640200 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 38640200 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study 38640348 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study 38640500 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study 38640500 — Predictive Biomarker (PRD): MME mRNA
Genes: MME; EPN
Study 38640622 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 38640937 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 38640937 — Safety Biomarker (SAF): HLA-DQA1
Genes: CELIAC1
Study 38641023 — Monitoring Biomarker (MOI): HBV DNA
Study 38641031 — Predictive Biomarker (PRD): MVD mRNA
Genes: MVD; MPD
Study 38641363 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 38641363 — Predictive Biomarker (PRD): ZEB1 mRNA
Genes: ZEB1; AREB6; TCF8
Study 38641363 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 38641363 — Safety Biomarker (SAF): miR-200a
Genes: MIR200A
Study 38641716 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 38641768 — Surrogate Endpoint (SUR): Forced vital capacity
Study 38641791 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 38641998 — Predictive Biomarker (PRD): TNFSF13 mRNA
Genes: TNFSF13; APRIL; TALL2; ZTNF2; UNQ383/PRO715
Study 38641998 — Surrogate Endpoint (SUR): Blood pressure
Study 38642245 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 38642245 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 38642245 — Predictive Biomarker (PRD): Hormone receptor
Study 38642937 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 38642937 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 38643086 — Predictive Biomarker (PRD): SST mRNA
Genes: SST
Study 38643311 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 38643346 — Predictive Biomarker (PRD): JAK1
Genes: JAK1A; JTK3
Study 38643510 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study 38643510 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 38643547 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 38644146 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 38644692 — Predictive Biomarker (PRD): CD80 mRNA
Genes: CD80; CD28LG; CD28LG1; LAB7
Study 38644692 — Pharmacodynamic Biomarker (PDY): T-lymphocyte activation antigen CD86
Genes: CD86; CD28LG2
Study 38644692 — Predictive Biomarker (PRD): Tumor-infiltrating lymphocyte
Study 38649069 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study 38649069 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 38649522 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 38649734 — Predictive Biomarker (PRD): KREMEN1 mRNA
Genes: KREMEN1; KREMEN; KRM1
Study 38649937 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 38650031 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 38650969 — Safety Biomarker (SAF): PPOX
Genes: HCRT; OX
Study 38650969 — Predictive Biomarker (PRD): BBOX1 mRNA
Genes: BBOX1; BBH; BBOX
Study 38651515 — Predictive Biomarker (PRD): RANGAP1 mRNA
Genes: RANGAP1; KIAA1835; SD
Study 38652200 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study 38652232 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 38652564 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 38652812 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study 38652812 — Safety Biomarker (SAF): RAS pathway
Study 38652877 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 38652877 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 38652877 — Predictive Biomarker (PRD): TACSTD2 mRNA
Genes: TACSTD2; GA733-1; M1S1; TROP2
Study 38652877 — Predictive Biomarker (PRD): Hormone receptor
Study 38653979 — Predictive Biomarker (PRD): CYP4V2 mRNA
Genes: CYP4V2
Study 38654004 — Surrogate Endpoint (SUR): Forced vital capacity
Study 38654329 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 38654416 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 38654917 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 38655676 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 38656229 — Surrogate Endpoint (SUR): Bone mineral density
Study 38656355 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 38656355 — Safety Biomarker (SAF): BDNF
Study 38656951 — Surrogate Endpoint (SUR): Blood pressure
Study 38656951 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 38657084 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 38657201 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study 38657201 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 38657244 — Predictive Biomarker (PRD): CD7 mRNA
Genes: CD7
Study 38657366 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study 38657366 — Predictive Biomarker (PRD): ATRX mRNA
Genes: ATRX; RAD54L; XH2
Study 38658017 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 38658392 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study 38658485 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 38658775 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 38659046 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study 38660276 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study 38660518 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study 38661071 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51